Summary
A joint guideline by the Australian Diabetes Society (ADS) and Australian and New Zealand Society of Nuclear Medicine (ANZSNM) for PET/CT imaging in patients with type 1 and type 2 diabetes.

The purpose of the guideline is to assist medical, nursing and nuclear medicine staff to prepare and manage people living with diabetes undergoing a PET scan. This guideline is for the provision of advice only and does not replace clinical decision making in individual patients or specific protocols adapted for individual centres.

Position Statement
Download the Joint ADS/ANZSNM guideline for FDG PET/CT imaging in patients with type 1 and type 2 diabetes (August 2024) – PDF